CULT Food Science to Commence Trading on the Canadian Securities Exchange on January 17, 2022

Jan 17, 2022

Cellular Agriculture Platform Offers Investors Democratized Access to Portfolio Companies that are Advancing the Development of Novel Technologies to Provide a Sustainable, Environmental and Ethical Solution to the Global Factory Farming and Aquaculture Crises

VANCOUVER, BC - CULT Food Science Corp., an innovative investment platform with an exclusive focus on clean, lab-grown food that is advancing the development of novel technologies to provide a sustainable, environmental and ethical solution to the global factory farming and aquaculture crises, is pleased to announce that its common shares have been approved for listing on the Canadian Securities Exchange (the "CSE") and will commence trading on Monday, January 17, 2022, under the stock ticker symbol "CULT". To coincide with its listing on the CSE, CULT has recently updated its website with new information about the Company and its investee businesses, including but not limited to a current investor presentation, which can all be viewed at https://www.cultfoodscience.com/.

Additionally, with the listing on the CSE complete, the Company will be pursuing options for increased liquidity for its shareholders in Europe and the United States. CULT also intends to submit an application to the Depository Trust Company (the "DTC") to have the Company's common shares eligible for delivery and depository services with the DTC to facilitate electronic settlement of transfers of its common shares in the United States. Securities that are eligible to be electronically cleared and settled through the DTC are considered "DTC eligible". This electronic method of clearing securities expedites the receipt of stock and cash, and thus accelerates the settlement process for investors and greatly reduces transaction costs for participating brokerages firms.

Click here to see more...

Video: New Solution Powers Efficient Pork Growth

Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.